Costs of potentially avoidable complications have significantly more variation than costs of typical care in selected chronic and procedural episodes.
Amita Rastogi, MD, MHA
Advertisement
Articles by Amita Rastogi, MD, MHA
Advertisement
Latest Updated Articles
- Episode of Care Analysis Reveals Sources of Variations in Costs
October 17th 2011
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
3
Measles Cases Climb to 2000 in the US, Increasing Cases Year Over Year
4
Survodutide Normalizes Liver Fat in 61% of Patients With MASLD in Phase 3 Trial: Lee Kaplan, MD, PhD
5